GAM Holding’s Meridian Bioscience Inc VIVO Stock Holding History

GAM Holding’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-39,200	Closed	-$1.3M	–	235
2022 Q4	$1.3M	Buy	+39,200	New	+$1.26M	0.1%	159

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAM Holding's VIVO Position: Q1 2023 in Review

GAM Holding sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 39,200 shares — an estimated $1.3M sold.

GAM Holding first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $1.3M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

GAM Holding reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
GAM Holding sold 39,200 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.3M.
GAM Holding first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
GAM Holding's Meridian Bioscience Inc position peaked at $1.3M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on GAM Holding's 13F filing for Q1 2023, filed 9 May 2023.